Диссертация (1139521), страница 52
Текст из файла (страница 52)
– 2010. – Vol. 470, Iss. 2. – P. 106–110.680. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators / D. Amantea [et al.] // FEBS J. – 2009. – Vol. 276, Iss. 1. – P. 13–26.312681. Prevalence and severity of microbleeds in a memory clinic setting /С. Cordonnier [et al.] // Neurology. – 2006. – Vol. 66, Iss.
9. – P. 1356–1360.682. Prevalence of disorders of executive cognitive functioning among elderly:findings from the San Luis Valley Health and Aging Study / J. Grigsby [et al.] // Neuroepidemilogy. – 2002. – Vol. 21, Iss. 5. – P. 213–220.683. Primary prevention of ischemic stroke: A Guideline from the AmericanHeart Association/American Stroke Association Stroke Council : Cosponsored by theAtherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity,and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of thisguideline / L.
B. Goldstein [et al.] // Stroke. – 2006. – Vol. 37, Iss. 6. – P. 1583–1633.684. Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats / T. D. Barrett [et al.] // Br. J. Pharmacol. – 2015. –Vol. 172, Iss. 16. – P. 4078–4088.685. Quinn, P. J. The effect of tocopherol on the structure and permeability ofphosphatidylcholine liposomes // J.
Control. Release. – 2012. – Vol. 160, Iss. 2. –P. 158–163.686. Rabkin, S. W. Comparison of vascular stiffness in vascular dementia, Alzheimer dementia and cognitive impairment / S. W. Rabkin, G. Jarvie // Blood Press. –2011. – Vol. 20, Iss. 5. – P. 274–283.687. Raichle, M E. The restless brain: how intrinsic activity organizes brain function // Philos. Trans.
R. Soc. B: Biol. Sci. – 2015. – Vol. 370, N 1668. – pii: 20140172.688. Raichle, M. E. Brain work and brain imaging / M. E. Raichle, M. A. Mintun// Annu. Rev. Neurosci. – 2006. – Vol. 29, Iss. 1. – P. 449–476.689. Raichle, M. E. Two views of brain function // Trends Cogn. Sci. – 2010. –Vol. 14, Iss. 4. – P. 180–190.690. Ramos-Fernandes, M. Matrix metalloproteinase-9 as a market acute ischemic stroke: asytematic review / M. Ramos-Fernandes, M. F. Bellolio, L. G. Stead // J.Stroke Cerebrovasc.
Dis. – 2011. – Vol. 20, Iss. 1. – P. 47–54.313691. Redox reactions of the α-synuclein-Cu2+ complex and their effects on neuronal cell viability / C. М. Wang [et al.] // Biochemistry. – 2010. – Vol. 49, Iss. 37. – P.8134–8142.692. Reijnders, J. Cognitive interventions in healthy older adults and people withmild cognitive impairment: a systematic review / J. Reijnders, C. van Heugten, M. vanBoxtel // Ageing Res. Rev. – 2013. – Vol. 12, Iss. 1. – P. 263–275.693. Remedi, M. S.
The mitochondria and insulin release: Nnt just a passing relationship / M. S. Remedi, C. G. Nichola, J. C. Koster // Cell Metab. – 2016. – Vol. 3, Iss.1. – P. 5–7.694. Resting-State Networks / R. K. Niazy [et al.] // fMRI: From Nuclear Spins toBrain Functions / K. Uludağ, K. Uğurbil, L. Berliner (eds.). – New York etc.: Springer,2015. – Ch. 14. Biological Magnetic Resonance. – P. 387–425.695. Ristow, M. Extending life span by increasing oxidative stress / M. Ristow, S.Schmeisser // Free Radic. Biol. Med. – 2011.
– Vol. 51, Iss. 2. – P. 327–336.696. Rohla, M. Metabolic syndrome, inflammation and atherothrombosis /M. Rohla, T. W. Weiss // Hamostaseologie. – 2013. – Vol. 33, no. 4. – P. 283–294.697. Role of adenosine and nitric oxide on the mechanisms of action of dipiridamole / R. Gamboa [et al.] // Stroke. – 2005. – Vol. 36, Iss. 10.
– P. 2170–2175.698. Role of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications / D. A. Chistiakov [et al.] // Biomed. Res. Ind. – 2014. – Vol.2014. – Article ID 610140, 14 pages.699. Role of vinpocetine in cerebrovascular diseases / S. Patyar [et al.] // Pharmacol. Rep. – 2011. – Vol. 63, Iss. 3. – P. 618–628.700. Román, G. Vascular dementia: distinguishing characteristics, treatment, andprevention // J. Am. Geriatr.
Soc. – 2003. – Vol. 51, Iss. 5. – P. S296–304.701. Rybnikova, E. Cuttent insights into the molecular mechanisms of hypoxicpre- and postconditioning using hypobaric hypoxia / E. Rybnikova, M. Samoilov //Front. Neurosci. – 2015. – N 9. – P. 388.314702. Salminen, A. Apoptosis and aging: increased resistance to apoptosis enhances the aging process / A. Salminen, J. Ojala, K. Kaarniranta // Cell. Mol. Life.
Sci. –2011. – Vol. 68, Iss. 6. – P. 1021–1031.703. Salthouse, T. A. Neuroanatomical substrates of age-related cognitive decline// Psychol. Bull. – 2011. – Vol. 137, Iss. 5. – P. 753–784.704. Samaja, M. Editorial – Hypoxia and reoxygenation: from basic science tobedside / M. Samaja, G. Milano // Front. Pediatr. – 2015. – Vol. 3.
– P. 86.705. Schmid, H. Investigational therapies for renal disease-induced anemia /H. Schmid, W. Jelkmann // Expert Opin. Investig. Drugs. – 2016. – Vol. 25, Iss. 8. –P. 901–916.706. Schmidtke, K. Cerebral small vessel disease: how does it progress? /K.
Schmidtke, M. Hüll // J. Neurol. Sciences. – 2005. – Vol. 229/230. – P. 13–20.707. Schonenberger, M. Hypoxia signaling pathways: modulators of oxygenrelated organelles / M. Schonenberger, W. Kovacs // Front. Cell Dev. Biol. – 2015. – 3:42. – https://doi.org/10.3389/fcell.2015.00042708. Screening for cardiovascular risk in asymptomaticpatients / J. S. Berger [etal.] // J.
Am. Coll. Cardiol. – 2010. – Vol. 55, Iss. 12. – P. 1169–1177.709. Selected cytokines and soluble forms of cytokine receptors in coronary artery disease / K. Mizia-Stec [et al.] // Eur. J. Intern. Med. – 2002. Vol. 13, Iss. 2. –P. 115–122.710. Semenza, G. L. Hypoxia-inducible factors in physiology and medicine //Cell. – 2012.
– Vol. 148, Iss. 3. – P. 399–408.711. Semenza, G. L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1 // Physiology (Bethesda). – 2009. – Vol. 24. – P. 97–106.712. Serum levels of cytokines and C-reactive protein in acute ischemic strokepatients, and their relationship to stroke lateralization, type, and infarct volume /H.
Ormstad [et al.] // J. Neurol. – 2011. – Vol. 258, Iss. 4. – P. 677–685.713. Shalev, H. Breaching the blood-brain barrier as gate to psychiatric disorder /H. Shalev, Y. Serlin, A. Friedman // Cardiovasc. Psychiatry Neurol. – 2009. – Vol.2009. – P. 1–7.315714. Shaw, A. C. Age-dependent dysregulation of innate immunity / A. C. Shaw,D.
R. Goldstein, R. R. Montgomery // Nat. Rev. Immunol. – 2013. – Vol. 13, Iss. 12. –P. 875–87.715. Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatricdepression / D. Steffens [et al.] // Int. J. Geriatr. Psychiatry. – 2008. – Vol. 23, Iss. 3.
–P. 244–248.716. Shulginova, A. A. Pharmacological management of immune and oxidativedisturbances in patients with encephalopathy on the background of hypertension / A. A.Shulginova, E. Yu. Voronina, N. A. Bystrova // Research result: pharmacology andclinical pharmacology. – 2016. – Vol. 2, – N 2. – P. 99–106.717. Sildenafil and a Compound Stimulating Endothelial NO Synthase ModifySexual Incentive Motivation and Copulatory Behavior in Male Wistar and Fisher 344Rats / X. Chu [et al.] // J. Sex. Med.
– 2008. – Vol. 5, Iss. 9. – P. 2085–2099.718. Simultaneous genotyping of multiple polymorphisms in human serotonintransporter gene and detection of novel allelic variants / R. Avula [et al.] // Transl. Psychiatry. – 2011. – Iss. 1. – P. 32–37.719. Sirtori, C. Aescin: pharmacology, pharmacokinetics and therapeutic profile// Chem. Pharm. Bull. (Tokyo).
– 2001. – Vol. 49, Iss. 5. – P. 626–628.720. Sleep disturbance and longitudinal risk of inflammation: Moderatinginflucnces of social integration and social isolation in the CoronaryArtery Risk Development in Young Adults (CARDIA) study / H. J. Choa [et al.] // Brain Behav. Immun. –2015. – Vol. 46. – P. 319–326.721. Soares, M. P. Tissue damage control in disease tolerance / M. P. Soares,R.
Gozzelino, S. Weis // Trends Immunol. – 2014. – Vol. 35, Iss. 10. – P. 483–494.722. Spooky sodium balance / J. Titze [et al.] // Kidney Int. – 2013. – Vol. 85, Iss.4. – P. 759–767.723. Srivastava, K. Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke / K. Srivastava, P. M. Bath, U. Bayraktutan // Cell Mol. Neurobiol. – 2012. – Vol. 32, Iss. 3. – P. 319–336.316724. Steinberg, D.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
